Arrue, A.; Olivas, O.; Erkoreka, L.; Alvarez, F.J.; Arnaiz, A.; Varela, N.; Bilbao, A.; Rodríguez, J.-J.; Moreno-Calle, M.T.; Gordo, E.;
et al. Multilocus Genetic Profile Reflecting Low Dopaminergic Signaling Is Directly Associated with Obesity and Cardiometabolic Disorders Due to Antipsychotic Treatment. Pharmaceutics 2023, 15, 2134.
https://doi.org/10.3390/pharmaceutics15082134
AMA Style
Arrue A, Olivas O, Erkoreka L, Alvarez FJ, Arnaiz A, Varela N, Bilbao A, Rodríguez J-J, Moreno-Calle MT, Gordo E,
et al. Multilocus Genetic Profile Reflecting Low Dopaminergic Signaling Is Directly Associated with Obesity and Cardiometabolic Disorders Due to Antipsychotic Treatment. Pharmaceutics. 2023; 15(8):2134.
https://doi.org/10.3390/pharmaceutics15082134
Chicago/Turabian Style
Arrue, Aurora, Olga Olivas, Leire Erkoreka, Francisco Jose Alvarez, Ainara Arnaiz, Noemi Varela, Ainhoa Bilbao, Jose-Julio Rodríguez, María Teresa Moreno-Calle, Estibaliz Gordo,
and et al. 2023. "Multilocus Genetic Profile Reflecting Low Dopaminergic Signaling Is Directly Associated with Obesity and Cardiometabolic Disorders Due to Antipsychotic Treatment" Pharmaceutics 15, no. 8: 2134.
https://doi.org/10.3390/pharmaceutics15082134
APA Style
Arrue, A., Olivas, O., Erkoreka, L., Alvarez, F. J., Arnaiz, A., Varela, N., Bilbao, A., Rodríguez, J. -J., Moreno-Calle, M. T., Gordo, E., Marín, E., Garcia-Cano, J., Saez, E., Gonzalez-Torres, M. Á., Zumárraga, M., & Basterreche, N.
(2023). Multilocus Genetic Profile Reflecting Low Dopaminergic Signaling Is Directly Associated with Obesity and Cardiometabolic Disorders Due to Antipsychotic Treatment. Pharmaceutics, 15(8), 2134.
https://doi.org/10.3390/pharmaceutics15082134
